Interbat Pharmaceuticals

Interbat Pharmaceuticals, established in 1948, is a leading Indonesian entity within the Pharmaceuticals and Healthcare sectors. It has solidified its position as one of the top five pharmaceutical manufacturers in Indonesia, demonstrating a long-standing commitment to health and well-being. The company specializes in producing over 270 medicines in various dosages and forms, catering to diverse medical needs. This extensive product range includes ethical pharmaceuticals, dental products, over-the-counter (OTC) medications, and aesthetic solutions, serving a broad clientele.

Operating with a workforce of 500 - 1,000 employees, Interbat Pharmaceuticals manages a significant scale of operations across 5 locations. The company generates substantial revenue, reported at $150.7M, underscoring its robust market presence and production capacity. To understand the driving force behind these operations, you can Meet Interbat Pharmaceuticals's team and learn about their leadership and expertise. Interbat's focus on continuous improvement and innovation is evident in its comprehensive product development.

Interbat Pharmaceuticals is driven by a philosophy of continuous improvement and innovation, deeply rooted in rigorous research and development. This commitment ensures the delivery of high-quality pharmaceutical solutions that enhance patient health outcomes. The company's strategic focus on quality control and adherence to industry best practices positions it as a reliable provider in the competitive healthcare landscape. Its long history and sustained growth highlight its enduring impact on the Indonesian pharmaceutical industry.